A detailed history of Livforsakringsbolaget Skandia, Omsesidigt transactions in Boston Scientific Corp stock. As of the latest transaction made, Livforsakringsbolaget Skandia, Omsesidigt holds 39,223 shares of BSX stock, worth $3.32 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
39,223
Previous 67,823 42.17%
Holding current value
$3.32 Million
Previous $4.65 Million 34.98%
% of portfolio
0.25%
Previous 0.39%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

SELL
$67.33 - $77.71 $1.93 Million - $2.22 Million
-28,600 Reduced 42.17%
39,223 $3.02 Million
Q4 2023

Jan 31, 2024

BUY
$48.64 - $57.81 $91,248 - $108,451
1,876 Added 2.84%
67,823 $3.92 Million
Q3 2023

Oct 20, 2023

SELL
$50.19 - $54.68 $150,570 - $164,040
-3,000 Reduced 4.35%
65,947 $3.48 Million
Q2 2023

Jul 06, 2023

SELL
$49.72 - $54.64 $343,068 - $377,016
-6,900 Reduced 9.1%
68,947 $3.73 Million
Q3 2022

Nov 14, 2022

SELL
$36.71 - $109.66 $855,343 - $2.56 Million
-23,300 Reduced 23.5%
75,847 $2.94 Million
Q2 2022

Aug 16, 2022

SELL
$35.24 - $47.1 $218,488 - $292,020
-6,200 Reduced 5.89%
99,147 $3.7 Million
Q1 2022

Jun 21, 2022

BUY
$40.9 - $45.1 $126,790 - $139,810
3,100 Added 3.03%
105,347 $4.67 Million
Q4 2021

Feb 14, 2022

BUY
$38.07 - $44.87 $1.55 Million - $1.83 Million
40,700 Added 66.13%
102,247 $4.34 Million
Q3 2021

Oct 28, 2021

BUY
$41.23 - $45.88 $1.27 Million - $1.41 Million
30,800 Added 100.17%
61,547 $2.67 Million
Q2 2021

Jul 13, 2021

BUY
$38.58 - $44.24 $358,794 - $411,432
9,300 Added 43.36%
30,747 $1.32 Million
Q4 2020

Mar 02, 2021

BUY
$33.15 - $41.97 $222,105 - $281,199
6,700 Added 45.43%
21,447 $771,000
Q1 2020

Apr 22, 2020

BUY
$25.83 - $45.71 $111,068 - $196,553
4,300 Added 41.16%
14,747 $481,000
Q4 2019

Jan 28, 2020

SELL
$37.87 - $45.37 $196,924 - $235,924
-5,200 Reduced 33.23%
10,447 $472,000
Q2 2019

Jul 19, 2019

BUY
$34.91 - $42.98 $69,820 - $85,960
2,000 Added 14.66%
15,647 $673,000
Q1 2019

May 09, 2019

BUY
$32.91 - $40.75 $46,073 - $57,050
1,400 Added 11.43%
13,647 $524,000
Q3 2018

Oct 26, 2018

SELL
$32.83 - $38.63 $403,809 - $475,149
-12,300 Reduced 50.11%
12,247 $472,000
Q2 2018

Jul 10, 2018

BUY
$26.84 - $34.32 $99,308 - $126,984
3,700 Added 17.75%
24,547 $803,000
Q4 2017

Jan 18, 2018

SELL
$24.79 - $29.8 $126,429 - $151,980
-5,100 Reduced 19.66%
20,847 $517,000
Q3 2017

Oct 12, 2017

BUY
$26.26 - $29.17 $681,368 - $756,873
25,947
25,947 $757,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $121B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Livforsakringsbolaget Skandia, Omsesidigt Portfolio

Follow Livforsakringsbolaget Skandia, Omsesidigt and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Livforsakringsbolaget Skandia, Omsesidigt, based on Form 13F filings with the SEC.

News

Stay updated on Livforsakringsbolaget Skandia, Omsesidigt with notifications on news.